Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study | Zendy

K. Robertson | Zendy; Hongyu Jiang | Zendy; Johnstone Kumwenda | Zendy; K Supparatpinyo | Zendy; Scott Evans | Zendy; Thomas Campbell | Zendy; Richard W. Price | Zendy; Srikanth Tripathy | Zendy; N. Kumarasamy | Zendy; Alberto La Rosa | Zendy; Breno Santos | Zendy; M. T. Silva | Zendy; Silvia M. Montano | Zendy; Cecilia Kanyama | Zendy; S. Badal Faesen | Zendy; Robert L. Murphy | Zendy; Colin D. Hall | Zendy; Christina M. Marra | Zendy; Cheryl Marcus | Zendy; Baiba Berzins | Zendy; R. Allen | Zendy; M. Housseinipour | Zendy; Farida Amod | Zendy; Ian Sanne | Zendy; James Hakim | Zendy; Ann Walawander | Zendy; Aspara Nair | Zendy

Open Access

Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study

Author(s) -

K. Robertson,

Hongyu Jiang,

Johnstone Kumwenda,

K Supparatpinyo,

Scott Evans,

Thomas Campbell,

Richard W. Price,

Srikanth Tripathy,

N. Kumarasamy,

Alberto La Rosa,

Breno Santos,

M. T. Silva,

Silvia M. Montano,

Cecilia Kanyama,

S. Badal Faesen,

Robert L. Murphy,

Colin D. Hall,

Christina M. Marra,

Cheryl Marcus,

Baiba Berzins,

R. Allen,

M. Housseinipour,

Farida Amod,

Ian Sanne,

James Hakim,

Ann Walawander,

Aspara Nair

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis507

Subject(s) - medicine , efavirenz , emtricitabine , neuropsychology , neurocognitive , randomized controlled trial , serostatus , verbal fluency test , pediatrics , psychiatry , viral load , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy , cognition

AIDS Clinical Trials Group (ACTG) A5199 compared the neurological and neuropsychological (NP) effects of 3 antiretroviral regimens in participants infected with human immunodeficiency virus type 1 (HIV-1) in resource-limited settings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research